Elmira Ibraim (Bucuresti, Romania), Lucy V. Baker (London, United Kingdom), Christoph Lange (Borstel, Germany)
Programmatic management of drug resistance tuberculosis: Outcome analysis of 200 patients in western part of Rajasthan, India
Sunil Kumar (Bharatpur, Rajasthan, India), Sunil Kumar, Kailash Sharma, K.C. Agarwal, Swetabh Purohit
|  |
Prevalence of rifampicin resistance by CB-NAAT in previously treated pulmonary tuberculosis cases
Mahendra kumar Bainara (Udaipur, India), Mahendra Kumar Bainara, Ananda Datta, Dinesh Kumar Sharma
| |
Indicators of rifampicin-resistant TB response in Belarus, 2009-2014
Alena Skrahina (Minsk region, Belarus), Alena Skrahina, Hennadz Hurevich, Andrei Astrauko, Dzmitry Klimuk, Liudmila Zhylevich, Valiantsin Rusovich, Masoud Dara, Andrei Dadu, Dennis Falzon
| |
Rifampicin and INH monoresistance prevalence among Iraqi smear positive pulmonary tuberculosis cases
Mohammad Abdulrazaq (Bagdad, Iraq), Mohammad Abdulrazaq, Layth Salih, Ahmed Mankhi, Hayder Al-Sikafi, Hussain Aldoori, Amar Zaidan, Samer Ameen, Talal Rajeb
|  |
Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva Anatolievna, Anastasia Samoilova, Larisa Chernousova, Tatev Bagdasaryan, Vadim Testov
| |
Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia)
Liudmila Pankratova (Saratov, Russian Federation), Liudmila Pankratova, Natalia Kazimirova, Inna Volchkova, Nikita Navolokin
| |
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
Namrata Kewalramani (Mumbai, India), Namrata Saxena, Vikas Agarwal, Amita Nene
| |
Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania
Cristina Marcella Popa (Bucuresti, Romania), Gilda Popescu, Cristina Popa, Victor Spinu, Popa Cristian
| |
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Daniel Wirth (Neuss, Germany), Daniel Wirth, Ramesh Dass, Robert Hettle
| |
Active drug-safety monitoring and management for tuberculosis patients treated with bedaquiline and linezolid, Belarus – 2014-2016
Alena Skrahina (Minsk region, Belarus), Alena Skrahina, Hennadz Hurevich, Dzmitry Viatushka, Varvara Solodovnikova, Dennis Falzon, Liudmila Zhylevich, Valiantsin Rusovich, Masoud Dara, Andrei Dadu, Pierpaolo de Colombani, George Sakvarelidze, Svetlana Setkina
| |
Treatment by linezolid of lung TB caused by drug resistant mycobacterium (MBT)
Mariya Pavlova (St Petersburg, Russian Federation), Mariya Pavlova, Anna Starshinova, Irina Chernokhaeva, Ekaterina Belyaeva, Nadezhda Sapozhnikova
| |
Changes in MIRU-VNTR profiles are associated with treatment failures in tuberculosis patients
Irina Kontsevaya (London, United Kingdom), Irina Kontsevaya, Vladyslav Nikolayevskyy, Alexander Kovalyov, Olga Ignatyeva, Edita Vasiliauskiene, Girts Skenders, Yanina Balabanova, Francis Drobniewski
| |
Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital
Olusoji Ige (Ibadan, Oyo, Nigeria), Olusoji Ige, Regina Oladokun
| |
Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Mani Tiwari (Allahabad, India), Mani Tiwari, Mahendra Patel
| |
Outcomes of directly observed treatment for drug resistant tuberculosis
Manu Chopra (Ranchi, India), Manu Chopra, C.D.S. Katoch, G.D.S. Madan, Barun Chakrabarty
| |
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Gina Gualano (Roma, Italy), Gina Gualano, Rocco Urso, Rosati Silvia, Tonnarini Roberto, Biagioli Daniele, Matteucci Giuseppe, Ghirga Piero, Murachelli Silvia, Di Caro Antonino, Biava Gianluigi, Goletti Delia, Girardi Enrico, Ippolito Giuseppe, Lauria Francesco Nicola, Palmieri Fabrizio
| |
Effect of treatment of drug resistant tuberculosis on thyroid stimulating hormone
Nilkanth Tukaram Awad (Mumbai, India), Nilkanth Tukaram Awad, Kunal Deokar, Jairaj Nair, Ganesh Dhangar, Mayur Devraj
| |
A study of prevalence of depression in patients with multi drug resistant tuberculosis
Ujaas Dawar (Ludhiana, India), Ujaas Dawar, Aditi Garg, Rajat Oswal, K.R. Patel
| |
Assessment of anti-tuberculosis activity of extracts of cinnamomum verum and solanun surattense along with isoniazid
Shashikant Vaidya (Mumbai, India), Shashikant Vaidya, Jaishankar Sharma, Jinesh Maniar, Nikita Prabhu, Mubina Mamawala, Suvarna Joshi-Pundit, Abhay Chowdhary
| |